Cian Healthcare Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 2,950,000 (47%) | — | ₹1,918 Cr |
| Retail | — | 2,950,000 (47%) | — | ₹1,918 Cr |
| Market Maker | — | 316,000 (5%) | — | ₹21 Cr |
| Σ Total | — | 6,216,000 (100%) | — | ₹40,404 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹130,000 |
| Retail (Max) | 13 | 26,000 | ₹1,690,000 |
| S-HNI (Min) | 14 | 28,000 | ₹1,820,000 |
| B-HNI (Min) | 67 | 134,000 | ₹8,710,000 |
Financial Statements Amount in Lakhs
| Metric | 31-Dec-18 | 31-Mar-18 | 31-Mar-17 |
|---|---|---|---|
| Revenue | 4,407 | 5,942 | 5,178 |
| Profit After Tax | 525 | 376 | 224 |
| Total Assets | 8,590 | 7,762 | 6,128 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Upgradation of existing plant i.e. Unit 1 situated at Roorkee, Uttarakhand India – 3.50
- 2 Margin money for Setting up of manufacturing facility i.e. Unit 2 situated at Roorkee, Uttarakhand, India – 7.28
- 3 Enhancement of our Company’s brand through advertising and other brand-building activities – 1.50
- 4 Long term working capital requirements – 10.00
- 5 Acquisitions and other strategic initiatives – 7.09
- 6 General corporate purposes – 4.74
Company Overview
Incorporated in 2003, Cian Healthcare Limited is a multinational manufacturing company certified by WHO-GMP & ISO -9001:2015 and Food and Drug Control Administration to work in the area of Food supplement, Sexual Wellness, Cosmeceuticals, Nutraceutical, Ayurvedic, and Pharmaceutical products. The manufacturing process of the company complies with the prescribed rules and regulations of the World Health Organization.
The company is engaged in developing, manufacturing and commercialising the pharmaceutical products under 12 therapeutic divisions and 10 sales division. The company operates the business under the brand and is also involved in government supplies, export and third-party manufacturing activities.
Products:
The product list of the company includes Sachet, Gels, Lotions, Creams, Ointments, Liquid Orals, Capsules, and Tablets. Apart from this, the company also owns a special licence to manufacture veterinary products such as Venky's and SAVAvet. The company manufactures pharmaceutical products for both the foreign and domestic markets.
Category wise sales:
As on 31st March 2018, the total company sale was comprising 37% from contract manufacturing, 24% from government supplies, 23% from franchise business, and 16% from export sales.
The competitive strengths of the company are:
1. PAN India presence
2. Promoters' 15 years of experience in the field
3. Good purchasing power
4. Strong distribution network
5. Low-cost operations